A recent preprint study investigated the efficacy of topical lidocaine for the treatment of chronic neck pain. The study used lidocaine patches with enhanced bioavailability in a randomized, placebo-controlled crossover design. The results showed no significant difference in reducing average neck pain scores between the lidocaine and placebo patch groups. However, the lidocaine patches showed a higher success rate compared to placebo. Subgroup analyses indicated that individuals with a shorter duration of neck pain, lower baseline Neck Disability Index scores, and younger age were more likely to have positive treatment outcomes. Further research is needed to evaluate products with higher dosing and penetrance and to apply more stringent selection criteria based on phenotyping to potentially achieve more significant outcomes in chronic neck pain treatment.
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article